389 related articles for article (PubMed ID: 24380965)
21. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
22. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.
Parker LA; Joshi A
Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568
[TBL] [Abstract][Full Text] [Related]
23. Ultra-low dose (+)-naloxone restores the thermal threshold of morphine tolerant rats.
Chou KY; Tsai RY; Tsai WY; Wu CT; Yeh CC; Cherng CH; Wong CS
J Formos Med Assoc; 2013 Dec; 112(12):795-800. PubMed ID: 24309169
[TBL] [Abstract][Full Text] [Related]
24. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice.
Lipták N; Dochnal R; Csabafi K; Szakács J; Szabó G
Regul Pept; 2013 Sep; 186():77-82. PubMed ID: 23891980
[TBL] [Abstract][Full Text] [Related]
25. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
Pinelli A; Cighetti G; Trivulzio S
Arzneimittelforschung; 2009; 59(2):72-8. PubMed ID: 19338137
[TBL] [Abstract][Full Text] [Related]
26. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
[TBL] [Abstract][Full Text] [Related]
27. Conditioned drug reward enhances subsequent spatial learning and memory in rats.
Zhai HF; Zhang ZY; Zhao M; Qiu Y; Ghitza UE; Lu L
Psychopharmacology (Berl); 2007 Dec; 195(2):193-201. PubMed ID: 17661018
[TBL] [Abstract][Full Text] [Related]
28. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.
Ghazal P; Ciccocioppo R; Ubaldi M
Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726
[TBL] [Abstract][Full Text] [Related]
29. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of morphine treatment regimen prior to mating and during late pregnancy.
Yim AJ; Miranda-Paiva CM; Flório JC; Oliveira CA; Nasello AG; Felicio LF
Brain Res Bull; 2006 Jan; 68(5):384-91. PubMed ID: 16377447
[TBL] [Abstract][Full Text] [Related]
31. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
Cui R; Suemaru K; Li B; Kohnomi S; Araki H
Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Popik P; Danysz W
J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
[TBL] [Abstract][Full Text] [Related]
33. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
Pinelli A; Trivulzio S
J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
[TBL] [Abstract][Full Text] [Related]
34. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
35. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence].
Konstantinopol'skiĭ MA; Cherniakova IV
Eksp Klin Farmakol; 2011; 74(10):12-6. PubMed ID: 22238980
[TBL] [Abstract][Full Text] [Related]
36. Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
Motoshima S; Suemaru K; Kawasaki Y; Jin C; Kawasaki H; Gomita Y; Araki H
Eur J Pharmacol; 2005 Sep; 519(1-2):91-5. PubMed ID: 16098507
[TBL] [Abstract][Full Text] [Related]
37. Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats.
Herzig V; Schmidt WJ
Neurosci Lett; 2005 Feb; 374(2):119-23. PubMed ID: 15644276
[TBL] [Abstract][Full Text] [Related]
38. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
39. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.
Glover EM; Davis M
Psychopharmacology (Berl); 2008 Jun; 198(2):167-80. PubMed ID: 18324390
[TBL] [Abstract][Full Text] [Related]
40. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
Dong Z; Han H; Cao J; Xu L
Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
